Abstract Submission for #BOPA2025 opens 31st March 2025

Abstract Submission for the 28th Annual BOPA Conference 2025 opens on 31st March 2025

 

Delegates are invited to present results of their clinical and technical work as a poster with some selected as an oral presentation. The author/s should submit via the BOPA website by midnight on Monday 23rd June. Abstracts will be reviewed and marked by the BOPA Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

 

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal.

 

Prizes:

• 1st Prize Oral Plenary: £1500 (to attend an international conference or pay towards research funding including open access publishing fees).
• 2nd Prize Oral Plenary: £500.

• All Oral Plenary presenters: free registration for BOPA 2026.
• All “Highly Recommended” presenters: free BOPA membership for 2026.
• The three best poster winners: free BOPA membership for 2026.

 

Click here for Call for Abstracts printable PDF

Click here for Abstract Marking Scheme as printable PDF 

 

Click here to go to the Abstract Submission Page

(Submission opens 31st March 2025)

 

Latest News

By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article
By BOPA Executive Committee on 24th August 2026

BOPA 2026 Executive Committee Election – Have you cast your vote for your candidates?

Have you cast your vote for the 2026 BOPA Executive Committee Election? In 2026 we received 9 nominations for 6 positions. -Standard Committee Member (6 places available) – VOTING FOR…

Read article